Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tosoh Corporation (4042.T)
Tokyo, JP
Tosoh Corporation is a global producer and supplier of a broad spectrum of chemical products, including basic chemicals, petrochemicals, specialty items, and fine chemicals. It conducts its business through four principal divisions: Petrochemical, Chlor-Alkali, Specialty, and Engineering. The company's extensive product catalog includes advanced materials such as battery components, engineered quartzware, silica glass, thin-film deposition materials, zeolites for catalysis and molecular sieving, and a variety of zirconia-based items (e.g., molded components, grinding media, and fine powders). Tosoh also provides specialized chromatographic columns and media, clinical diagnostic systems, and construction-grade products like Portland and blast-furnace slag cements. Its chemical offerings span the Chlor-Alkali segment with products like caustic soda, vinyl chloride monomer, calcium hypochlorite, and sodium bicarbonate; and the Petrochemical sector with ethylene, propylene, C4 fractions, tertiary butyl alcohol, cumene, and aromatic compounds. Additionally, it develops and supplies a host of specialty chemicals, including ethyleneamines, bromine compounds, hydrobromic acids, flame retardants, non-aqueous solvents, and chelating agents. Tosoh's polymer portfolio features diverse types including ethylene vinyl-acetate copolymers, adhesive polymers, low and high-density polyethylenes, synthetic rubbers, functional polymers, and polyvinyl chloride pastes. It is also a key manufacturer of polyurethanes, offering a range of diisocyanates (MDI, TDI, HDI), polyisocyanates for paints, polyols, adhesives, coating resins, and elastomers. Complementing its manufacturing activities, the company provides water treatment systems, undertakes construction and repair projects, and delivers essential corporate services encompassing logistics, analytical testing, human resources management, and information technology.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.50% | -2.56% | +10.48% | +0.00% | +15.27% | +10.55% | +28.06% | +56.14% | +27.66% | +157.44% | +243.47% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 6 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals: +4.0%-4.1% Q1'26: -1.4% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-27.3% Q1'26: +83.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+4.4% Q1'26: +8.7% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+9.4% ★ Q1'26: +9.7% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.3% ★ Q1'26: +8.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%-1.3% ★ Q1'26: -2.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×1.59× ★ Q1'26: 1.51× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 4 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 7 Rev. Ana. 7 EPS Ana. |
Mar 2029 2 Rev. Ana. 2 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
809.68B
est: 811.52B (-0.2%)
|
753.74B
est: 766.17B (-1.6%)
|
743.03B
est: 718.66B (+3.4%)
|
822.86B
est: 821.50B (+0.2%)
|
861.46B
est: 868.34B (-0.8%)
|
786.08B
est: 790.35B (-0.5%)
|
732.85B
est: 727.93B (+0.7%)
|
918.58B
est: 914.56B (+0.4%)
|
1.06T
est: 1.09T (-1.9%)
|
1.01T
est: 1.02T (-1.2%)
|
1.06T
est: 1.08T (-1.4%)
|
1.03T
1.01T – 1.04T
-4.8% YoY
|
1.08T
1.04T – 1.10T
+4.9% YoY
|
1.11T
1.05T – 1.16T
+3.5% YoY
|
1.08T
1.04T – 1.11T
-3.4% YoY
|
1.10T
1.07T – 1.13T
+2.5% YoY
|
| EBITDA |
87.11B
est: 130.95B (-33.5%)
|
104.21B
est: 123.63B (-15.7%)
|
141.63B
est: 115.96B (+22.1%)
|
163.31B
est: 132.56B (+23.2%)
|
140.31B
est: 140.12B (+0.1%)
|
116.58B
est: 127.53B (-8.6%)
|
128.28B
est: 117.46B (+9.2%)
|
184.71B
est: 147.58B (+25.2%)
|
117.67B
est: 175.08B (-32.8%)
|
124.36B
est: 152.28B (-18.3%)
|
146.41B
est: 161.40B (-9.3%)
|
153.72B
151.55B – 156.16B
-4.8% YoY
|
161.19B
156.25B – 164.36B
+4.9% YoY
|
166.79B
157.00B – 173.08B
+3.5% YoY
|
161.05B
156.06B – 166.04B
-3.4% YoY
|
165.13B
160.08B – 168.38B
+2.5% YoY
|
| EBIT |
51.40B
est: 93.80B (-45.2%)
|
69.44B
est: 88.56B (-21.6%)
|
111.22B
est: 83.07B (+33.9%)
|
130.58B
est: 94.96B (+37.5%)
|
105.74B
est: 100.37B (+5.4%)
|
81.66B
est: 91.35B (-10.6%)
|
87.82B
est: 84.14B (+4.4%)
|
144.05B
est: 105.71B (+36.3%)
|
74.61B
est: 125.42B (-40.5%)
|
79.85B
est: 105.68B (-24.4%)
|
98.91B
est: 112.01B (-11.7%)
|
106.68B
105.18B – 108.38B
-4.8% YoY
|
111.87B
108.44B – 114.07B
+4.9% YoY
|
115.76B
108.96B – 120.13B
+3.5% YoY
|
111.77B
108.31B – 115.24B
-3.4% YoY
|
114.61B
111.10B – 116.86B
+2.5% YoY
|
| Net Income |
62.30B
est: 64.94B (-4.1%)
|
39.68B
est: 42.12B (-5.8%)
|
75.66B
est: 69.71B (+8.5%)
|
88.80B
est: 88.68B (+0.1%)
|
78.13B
est: 70.88B (+10.2%)
|
55.55B
est: 55.81B (-0.5%)
|
63.28B
est: 54.83B (+15.4%)
|
107.94B
est: 98.57B (+9.5%)
|
50.34B
est: 61.02B (-17.5%)
|
57.33B
est: 60.33B (-5.0%)
|
58.00B
est: 62.33B (-6.9%)
|
35.33B
32.21B – 40.00B
-43.3% YoY
|
63.02B
60.94B – 65.09B
+78.4% YoY
|
66.00B
56.15B – 77.08B
+4.7% YoY
|
69.50B
60.88B – 76.90B
+5.3% YoY
|
73.16B
70.25B – 75.03B
+5.3% YoY
|
| SGA |
84.75B
est: 105.74B (-19.8%)
|
85.89B
est: 99.83B (-14.0%)
|
87.74B
est: 93.64B (-6.3%)
|
92.84B
est: 107.04B (-13.3%)
|
97.18B
est: 113.14B (-14.1%)
|
98.70B
est: 102.98B (-4.2%)
|
94.32B
est: 94.85B (-0.6%)
|
105.10B
est: 119.16B (-11.8%)
|
119.48B
est: 141.38B (-15.5%)
|
120.36B
est: 122.15B (-1.5%)
|
132.91B
est: 129.47B (+2.7%)
|
123.30B
121.57B – 125.27B
-4.8% YoY
|
129.30B
125.34B – 131.84B
+4.9% YoY
|
133.80B
125.94B – 138.84B
+3.5% YoY
|
129.19B
125.18B – 133.19B
-3.4% YoY
|
132.46B
128.41B – 135.07B
+2.5% YoY
|
| EPS |
207.94
est: 203.90 (+2.0%)
|
125.22
est: 132.26 (-5.3%)
|
233.12
est: 218.86 (+6.5%)
|
273.49
est: 278.43 (-1.8%)
|
240.62
est: 222.53 (+8.1%)
|
171.03
est: 175.23 (-2.4%)
|
197.89
est: 172.14 (+15.0%)
|
339.23
est: 309.48 (+9.6%)
|
158.14
est: 191.57 (-17.4%)
|
180.03
est: 189.49 (-5.0%)
|
182.13
est: 197.09 (-7.6%)
|
114.34
101.14 – 125.60
-42.0% YoY
|
199.27
191.34 – 204.37
+74.3% YoY
|
220.64
176.28 – 242.01
+10.7% YoY
|
216.30
191.16 – 241.44
-2.0% YoY
|
229.70
220.56 – 235.57
+6.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Goldman Sachs Data Enhanced International Equity ETF GIEQ | 0.47% | 48.5K | 0.30% |
| 2 | iShares MSCI Japan Small Cap UCITS ETF IDJP.L | 0.34% | 1.90M | 0.58% |
| 3 | iShares MSCI Japan Small-Cap ETF SCJ | 0.33% | 846.3K | 0.50% |
| 4 | Hartford Multifactor Developed Markets (ex-US) ETF RODM | 0.25% | 3.91M | 0.29% |
| 5 | WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc DXJF.MI | 0.21% | 2.00M | 0.45% |
| 6 | WisdomTree Japan Equity UCITS ETF - USD Acc DXJZ.L | 0.21% | 1.76M | 0.40% |
| 7 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.21% | 1.76M | 0.48% |
| 8 | WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc DXJD.SW | 0.21% | 2.17M | 0.45% |
| 9 | WisdomTree Japan Equity UCITS ETF - USD Hedged Acc DXJA.L | 0.21% | 1.76M | 0.48% |
| 10 | WisdomTree Japan Equity UCITS ETF - GBP Hedged DXJP.L | 0.21% | 2.35M | 0.45% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mamoru Kuwada | President & Representative Director | 101M | male |
| Akira Takano | Vice President & GM of Human Resources | — | male |
| Hiroshi Ogawa | Senior Vice President & Deputy Senior General Manager of Research Division | — | — |
| Masashige Sakata | Vice President & GM of Corporate Control & Accounting | — | — |
| Nobukatsu Ohmichi | Executive Vice President, President of Specialty Group & Director | — | — |
| Takahiko Kamezaki | Executive Vice President, President of Petrochemical Group, GM of Purchasing & Logistics and Director | — | male |
| Teruhiko Ide | Senior Vice President, GM of Adv. Inte. Res. Cntr, GM of Life Sci. Res. Lab. & GM of Tokyo Res. Cntr. | — | — |
| Toru Adachi | Senior Executive Vice President, President of Taiyo Vinyl Corporation & Representative Director | — | male |
| Akihiro Yoshimizu | Executive Vice President, President of Engineering Group, Senior GM of Technology Division & Director | — | male |
| Yutaka Murata | Senior Vice President & Senior GM of Yokkaichi Complex | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4042.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
